-
Menarini Group Reports Data from the Phase 3 SENTRY Trial of Selinexor Plus Ruxolitinib in Myelofibrosis at The European Hematology Association (EHA) 2026 Congress
The combination of selinexor plus ruxolitinib met the first co-primary endpoint demonstrating a statistically significant improvement of spleen volume reduction (SVR35) of 49.8% for the combination arm vs 28% for the control arm at week 24. Post-hoc analysis from the phase 3 SENTRY trial suggests SVR35 may predict overall survival (OS); new data from the…
-
GNI Group to Acquire Ayumi Pharmaceutical Holdings, Expanding Its Position as a Global Biopharmaceutical Company
Transaction Establishes a Large-Scale Pharmaceutical Platform in Japan and Strengthens Commercial Capabilities Across Key Therapeutic Areas June 07, 2026 19:41 ET | Source: GNI Group Co., Ltd. TOKYO, June 07, 2026 (GLOBE NEWSWIRE) — GNI Group Co., Ltd. (TSE: 2160) today announced that it has entered into an agreement to acquire 100% of the shares…
-
SMPP Enters into Teaming Agreement with KNDS for KATANA®
SMPP, one of India’s leading defence and aerospace companies, has entered into a teaming agreement through its subsidiary SMPP Ammunition with KNDS for the KATANA® range of precision-guided artillery ammunition. The KATANA® is a 155mm precision-guided munition designed to deliver high accuracy and extended range, addressing critical operational needs of modern artillery systems. The agreement…
-
Havih, a Maxwell Biosciences Subsidiary, Announces Partnership with the Government of Andhra Pradesh
This partnership will establish a new research and production facility in Andhra Pradesh, driving India’s transition toward pharmaceutical leadership and creating high-tech jobs Pulivendula, Andhra Pradesh, India Havih Envirosciences, an Indian citizen-owned and operated life sciences company and subsidiary of Maxwell Biosciences, announced a strategic partnership with the Government of Andhra Pradesh to establish advanced…
Latest News
About the Author
We increase the awareness of millions of users through our news networks. We are one of the most trusted news networks in the world.
